|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/69 | |
| A61K 47/54 | |||
| A61K 9/127 | |||
| A61P 35/00 |
| (11) | Number of the document | 3151864 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15733015.0 |
| Date of filing the European patent application | 2015-06-09 | |
| (97) | Date of publication of the European application | 2017-04-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/034897 |
| Date | 2015-06-09 |
| (87) | Number | WO 2015/191576 |
| Date | 2015-12-17 |
| (30) | Number | Date | Country code |
| 201462009767 P | 2014-06-09 | US | |
| 201562120637 P | 2015-02-25 | US |
| (72) |
GABIZON, Alberto, IL
OHANA, Patricia, IL
WANG, Andrew, US
|
| (73) |
Lipomedix Pharmaceuticals Ltd.,
POB 39262, 9139102 Jerusalem,
IL
The University of North Carolina at Chapel Hill, 100 Europa Drive Suite 430, Chapel Hill, NC 27517, US |
| (54) | COMBINATION THERAPY COMPRISING A LIPOSOMAL PRODRUG OF MITOMYCIN C AND RADIOTHERAPY |
| COMBINATION THERAPY COMPRISING A LIPOSOMAL PRODRUG OF MITOMYCIN C AND RADIOTHERAPY |